Ellen O'Connor Vos insider trades
Open-market stock purchases and sales by Ellen O'Connor Vos, Director at OptimizeRx Corp, from SEC Form 4 filings since Nov 11, 2011.
Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -52%.